Another Secondary Announced 2.17.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Neurocrine Biosciences
Symbol: NBIX
Price: Last trade $37.33
Trade Date: 2/19
Shares: 6 million
Underwriter(s) J.P. Morgan, Deutsche Bank Securities
Rating=Subscription Needed

Company: Aramark
Symbol: ARMK
Price: Last trade $30.24
Trade Date: 2/18
Shares: 30 million
Underwriter(s) Credit Suisse
Rating=Subscription Needed

Company: Cenovus Energy Inc.
Symbol: CVE
Price: Last trade $18.83
Trade Date: 2/18
Shares: 67.5 million
Underwriter(s) RBC Capital Markets, TD Securities, Inc.
Rating=Subscription Needed